246 related articles for article (PubMed ID: 35572129)
1. Multi-Omics Integration in Mice With Parkinson's Disease and the Intervention Effect of Cyanidin-3-
Wang W; Zhu G; Wang Y; Li W; Yi S; Wang K; Fan L; Tang J; Chen R
Front Aging Neurosci; 2022; 14():877078. PubMed ID: 35572129
[TBL] [Abstract][Full Text] [Related]
2. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
Chen R; Wang J; Zhan R; Zhang L; Wang X
J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
[TBL] [Abstract][Full Text] [Related]
3. Curcumin-driven reprogramming of the gut microbiota and metabolome ameliorates motor deficits and neuroinflammation in a mouse model of Parkinson's disease.
Cui C; Han Y; Li H; Yu H; Zhang B; Li G
Front Cell Infect Microbiol; 2022; 12():887407. PubMed ID: 36034698
[TBL] [Abstract][Full Text] [Related]
4. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Induced Parkinson's Disease in Mouse: Potential Association between Neurotransmitter Disturbance and Gut Microbiota Dysbiosis.
Zhu Y; Huan F; Wang J; Xie X; Yu G; Wang X; Jiang L; Gao R; Xiao H; Ding H; Wang J
ACS Chem Neurosci; 2020 Oct; 11(20):3366-3376. PubMed ID: 32926778
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota influenced the xenograft MC38 tumor growth potentially through interfering host lipid and amino acid metabolisms, basing on the integrated analysis of microbiome and metabolomics.
Chen MH; Zhou J; Wu CY; Zhang W; Long F; Zhou SS; Xu JD; Wu J; Zou YT; Li SL; Shen H
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Mar; 1192():123136. PubMed ID: 35151210
[TBL] [Abstract][Full Text] [Related]
6. Cyanidin-3-O-glucoside impacts fecal discharge of polystyrene microplastics in mice: Potential role of microbiota-derived metabolites.
Chen W; Tu P; Ye X; Tang Q; Yu T; Zheng X
Toxicol Appl Pharmacol; 2022 Oct; 453():116212. PubMed ID: 36057402
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway.
Sun MF; Zhu YL; Zhou ZL; Jia XB; Xu YD; Yang Q; Cui C; Shen YQ
Brain Behav Immun; 2018 May; 70():48-60. PubMed ID: 29471030
[TBL] [Abstract][Full Text] [Related]
8. Integrated multi-omics profiling highlights the benefits of resveratrol hydroxypropyl-β-cyclodextrin inclusion complex for A53T transgenic mice through the microbiota-gut-brain axis.
Sun X; Feng S; Qin B; Ye J; Xie L; Gui J; Sang M
Food Funct; 2024 Feb; 15(3):1489-1512. PubMed ID: 38227477
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic-Induced Dysbiosis of Microbiota Promotes Chicken Lipogenesis by Altering Metabolomics in the Cecum.
Zhang T; Ding H; Chen L; Lin Y; Gong Y; Pan Z; Zhang G; Xie K; Dai G; Wang J
Metabolites; 2021 Jul; 11(8):. PubMed ID: 34436428
[TBL] [Abstract][Full Text] [Related]
10. Integrated 16S rRNA Gene Sequencing and Metabolomics Analysis to Investigate the Important Role of Osthole on Gut Microbiota and Serum Metabolites in Neuropathic Pain Mice.
Li R; Wang F; Dang S; Yao M; Zhang W; Wang J
Front Physiol; 2022; 13():813626. PubMed ID: 35197864
[TBL] [Abstract][Full Text] [Related]
11. Altered gut microbiota in Parkinson's disease patients/healthy spouses and its association with clinical features.
Zhang F; Yue L; Fang X; Wang G; Li C; Sun X; Jia X; Yang J; Song J; Zhang Y; Guo C; Ma G; Sang M; Chen F; Wang P
Parkinsonism Relat Disord; 2020 Dec; 81():84-88. PubMed ID: 33099131
[TBL] [Abstract][Full Text] [Related]
12. An analysis of the characteristics of the intestinal flora in patients with Parkinson's disease complicated with constipation.
Chen W; Bi Z; Zhu Q; Gao H; Fan Y; Zhang C; Liu X; Ye M
Am J Transl Res; 2021; 13(12):13710-13722. PubMed ID: 35035709
[TBL] [Abstract][Full Text] [Related]
13. Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson's Disease.
Lai F; Jiang R; Xie W; Liu X; Tang Y; Xiao H; Gao J; Jia Y; Bai Q
Neurochem Res; 2018 Oct; 43(10):1986-1999. PubMed ID: 30171422
[TBL] [Abstract][Full Text] [Related]
14. Gut Microbiota and Metabolome Alterations Associated with Parkinson's Disease.
Vascellari S; Palmas V; Melis M; Pisanu S; Cusano R; Uva P; Perra D; Madau V; Sarchioto M; Oppo V; Simola N; Morelli M; Santoru ML; Atzori L; Melis M; Cossu G; Manzin A
mSystems; 2020 Sep; 5(5):. PubMed ID: 32934117
[TBL] [Abstract][Full Text] [Related]
15. Electroacupuncture at ST25 corrected gut microbial dysbiosis and SNpc lipid peroxidation in Parkinson's disease rats.
Hu XM; Song LZ; Zhang ZZ; Ruan X; Li HC; Yu Z; Huang L
Front Microbiol; 2024; 15():1358525. PubMed ID: 38450172
[TBL] [Abstract][Full Text] [Related]
16. Oral, Nasal, and Gut Microbiota in Parkinson's Disease.
Li Z; Lu G; Luo E; Wu B; Li Z; Guo J; Xia Z; Zheng C; Su Q; Zeng Y; Chan WY; Su X; Qiu X; Zheng X; Cai Q; Xu Y; Chen Y; Fan Y; Chen W; Yu Z; Chen X; Zheng C; Wang M; Poon WS; Luo X
Neuroscience; 2022 Jan; 480():65-78. PubMed ID: 34695538
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of dioscin against Parkinson's disease via regulating bile acid metabolism through remodeling gut microbiome/GLP-1 signaling.
Mao Z; Hui H; Zhao X; Xu L; Qi Y; Yin L; Qu L; Han L; Peng J
J Pharm Anal; 2023 Oct; 13(10):1153-1167. PubMed ID: 38024855
[TBL] [Abstract][Full Text] [Related]
18. Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis.
Zhao Z; Ning J; Bao XQ; Shang M; Ma J; Li G; Zhang D
Microbiome; 2021 Nov; 9(1):226. PubMed ID: 34784980
[TBL] [Abstract][Full Text] [Related]
19. Ketogenic diet protects MPTP-induced mouse model of Parkinson's disease via altering gut microbiota and metabolites.
Jiang Z; Wang X; Zhang H; Yin J; Zhao P; Yin Q; Wang Z
MedComm (2020); 2023 Jun; 4(3):e268. PubMed ID: 37200942
[TBL] [Abstract][Full Text] [Related]
20. Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson's disease via gut microbiota-GLP-1 pathway.
Sun J; Li H; Jin Y; Yu J; Mao S; Su KP; Ling Z; Liu J
Brain Behav Immun; 2021 Jan; 91():703-715. PubMed ID: 33148438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
